Artificial Intelligence
Helfie AI Partners With Kenya’s Homa Bay County to Pilot AI-Powered Health Screening for 100,000 People
Helfie AI ("Helfie"), an AI-powered preventive network transforming global healthcare, announced it has signed a Memorandum of Understanding (MOU) wi...
October 12, 2026 | News
GenScript and NVIDIA Launch Global PitchFest to Accelerate AI-Driven Drug Discovery Startups
GenScript Biotech Corporation announced the GenScript and NVIDIA Life Sciences Startup PitchFest, a global competition for startups applying arti...
October 12, 2026 | News
XtalPi Launches AI-Powered Kodexia Platform to Accelerate siRNA Drug Discovery
This unified platform integrates sequence design, chemical modification, experimental validation, extrahepatic delivery design, and intellectual property...
October 08, 2026 | News
QIAGEN Expands AI Push with New Tools for Biological Research and Drug Discovery
New IPA Investigator lets researchers ask biological questions in natural language and examine the scientific evidence behind the results New QIAGEN D...
October 08, 2026 | News
Sartorius and MAbSilico Unite AI and Cell Line Development to Accelerate Biologics Discovery
Sartorius and MAbSilico are collaborating to connect Al-driven protein discovery with automated, high-throughput cell line development The integrate...
October 02, 2026 | News
Suvoda Expands Unified Clinical Trial Platform With AI-Powered Capabilities
- Suvoda, a global clinical trial technology company, announced a new release of important advancements since unifying the market-leading Suvoda...
October 02, 2026 | News
Health In Tech Launches AI-Powered HitRix Platform for Large-Group Health Insurance
AI-powered HitRix platform streamlines large-group submissions, multi-market quoting, proposal comparison and placement in one secure environment, thereby ...
October 02, 2026 | News
CAS and Novartis Partner to Build AI-Ready Reaction Data Platform for Drug Discovery
Researchers will gain an integrated synthetic data foundation and an advanced custom search platform to support reaction data discovery and analysis ...
October 01, 2026 | News
Leo Cancer Care Advances Upright Radiation Therapy Experience for Children
Leo Cancer Care has announced plans to further invest in the treatment experience for children undergoing radiation therapy. Following the world's fi...
September 29, 2026 | News
XtalPi Files US FDA IND for AI-Designed Gut-Restricted Pan-TRK Inhibitor KQTD-126
This milestone marks the first IND submission from XtalPi's proprietary pipeline, recently unveiled in its interim results, validating the company's ...
September 28, 2026 | News
Nutshell Therapeutics Secures FDA IND Clearance for AI-Discovered NRF2 Degrader NTS231
Nutshell Therapeutics (Shanghai) Co., Ltd. ("Nutshell Therapeutics"), an innovative biotech company focused on AI-driven allosteric drug discovery, announc...
September 28, 2026 | News
Earendil Labs, Genentech Ink $1.5B+ Deal to Develop AI-Driven Bispecific Antibodies
Earendil Labs, an AI-powered biotechnology company advancing next-generation biologics, today announced a research collaboration with Genentech, a member o...
September 25, 2026 | News
Tech Mahindra, Verato Partner to Strengthen Data Foundations for AI-Driven Healthcare
The partnership gives U.S. health systems, payers, pharma, and device makers a trusted way to match patient, provider, and member records as they modernize...
September 25, 2026 | News
Tsingke Launches High-Throughput Validation Workflow for AI-Designed Proteins and Antibodies
Tsingke announced an integrated high-throughput validation workflow designed to help researchers experimentally evaluate large libraries of AI-designed pro...
September 24, 2026 | News
Most Read
- Can APAC Biomanufacturing Decarbonise Without Pricing Itself Out?
- The Algorithm on the GMP Floor: AI Promises a Smarter Plant. Regulators Demand the Audit Trail.
- APAC's Peptide-Capacity Gamble
- After the Rush: APAC's mRNA and Vaccine Capacity Hangover
- The Biosimilar Race: Factory to the World — or Stuck in the Copycat Economy?
- The Vein-to-Vein Problem: Can APAC's Cold Chain Carry Advanced Therapies?
- Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck
- Can APAC Build Radioligand Therapy Before the Atoms Decay?
- The Great Biopharma Reset: 50 Developments That Changed Everything in H1 2026
- Beyond the Trial: Can Real-World Evidence Earn Regulatory Trust in APAC?
- Beyond the Obvious Giant: Where APAC's Clinical Trials Go Next
- The Frontier That Won’t Quite Arrive
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
